CHA Biotech will acquire Jayjun Cosmetic, a cosmetics manufacturer listed on the main board, by putting a subsidiary out front.
According to the investment industry on the 30th, CHA Healthcare, a subsidiary of CHA Biotech, will take part in the paid-in capital increase that Jayjun Cosmetic is conducting and is set to become the new largest shareholder. Other affiliates besides CHA Healthcare are also expected to join this acquisition battle. They are said to pay around 30,000 won per share, including a management control premium.
As a result, Jayjun Cosmetic is set to welcome a new largest shareholder in just four months. Earlier, the Meta X No. 1 Fund participated in the 10 billion won paid-in capital increase that the company pushed on Jun. and secured equity equivalent to the largest shareholder.
Jayjun Cosmetic, which manufactures cosmetics such as sheet masks, has gone through significant ups and downs. Initially, the company played a key role in the SSANGBANGWOOL Group's governance structure. As the largest shareholder of Kanglim, a core unit of the SSANGBANGWOOL Group, it formed a circular shareholding chain running SSANGBANGWOOL → VIVIEN → DMOA → NS ENM → Jayjun Cosmetic → Kanglim → SSANGBANGWOOL.
However, as the SSANGBANGWOOL Group was dismantled, affiliates were sold and Jayjun Cosmetic's governance structure also changed. Leaving intact the equity held by NS ENM, the former largest shareholder, the company brought in new investors through a third-party paid-in capital increase.
Jayjun Cosmetic's share price is showing a sharp rise on the day. After climbing more than 11% the previous day, it hit the daily price limit on the day.